147 related articles for article (PubMed ID: 8115425)
1. Barrel rotation induced by central arginine8-vasopressin treatment: involvement of neurohypophyseal peptide receptors.
Diamant M; Baars AM; Kovács GL; De Wied D
Pharmacol Biochem Behav; 1994 Jan; 47(1):27-32. PubMed ID: 8115425
[TBL] [Abstract][Full Text] [Related]
2. Antipyretic effect of central arginine8-vasopressin treatment: V1 receptors specifically involved?
Kovacs GL; Baars AM; De Wied D
Life Sci; 1992; 50(21):1625-30. PubMed ID: 1315900
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of centrally injected AVP on heart rate, core temperature, and behavior in rats.
Diamant M; De Wied D
Am J Physiol; 1993 Jan; 264(1 Pt 2):R51-61. PubMed ID: 8430886
[TBL] [Abstract][Full Text] [Related]
4. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
Croiset G; De Wied D
Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
[TBL] [Abstract][Full Text] [Related]
5. Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor?
de Wied D; Elands J; Kovács G
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1494-8. PubMed ID: 1847526
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine-vasopressin.
Manning M; Stoev S; Bankowski K; Misicka A; Lammek B; Wo NC; Sawyer WH
J Med Chem; 1992 Jan; 35(2):382-8. PubMed ID: 1531076
[TBL] [Abstract][Full Text] [Related]
7. Oxytocin pretreatment enhances arginine vasopressin-induced motor disturbances and arginine vasopressin-induced phosphoinositol hydrolysis in rat septum: a cross-sensitization phenomenon.
Poulin P; Pittman QJ
J Neuroendocrinol; 1993 Feb; 5(1):33-9. PubMed ID: 8387375
[TBL] [Abstract][Full Text] [Related]
8. Vasopressin enhances the clearance of beta-endorphin immunoreactivity from rat cerebrospinal fluid.
Sweep CG; Boomkamp MD; Barna I; Logtenberg AW; Wiegant VM
Acta Endocrinol (Copenh); 1990 Feb; 122(2):191-200. PubMed ID: 2138399
[TBL] [Abstract][Full Text] [Related]
9. Vasopressin-induced sensitization: involvement of neurohypophyseal peptide receptors.
Poulin P; Szot P; Dorsa DM; Pittman QJ
Eur J Pharmacol; 1995 Dec; 294(1):29-39. PubMed ID: 8788413
[TBL] [Abstract][Full Text] [Related]
10. Arginine vasopressin increases renal sodium excretion in the anesthetized rat through V1 receptors.
Musabayane CT; Forsling ML; Balment RJ
Ren Fail; 1997 Jan; 19(1):23-32. PubMed ID: 9044449
[TBL] [Abstract][Full Text] [Related]
11. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
[TBL] [Abstract][Full Text] [Related]
12. Central cardiovascular effects of AVP and AVP analogs with V1, V2 and 'V3' agonistic or antagonistic properties in conscious dog.
Noszczyk B; Lon S; Szczepańska-Sadowska E
Brain Res; 1993 Apr; 610(1):115-26. PubMed ID: 8518919
[TBL] [Abstract][Full Text] [Related]
13. Effects of central vasopressin administration to infant rats.
Winslow JT; Insel TR
Eur J Pharmacol; 1993 Mar; 233(1):101-7. PubMed ID: 8472738
[TBL] [Abstract][Full Text] [Related]
14. Barrel rotation in rats induced by SMS 201-995: suppression by ceruletide.
Ishikawa Y; Shimatsu A; Murakami Y; Imura H
Pharmacol Biochem Behav; 1990 Nov; 37(3):523-6. PubMed ID: 2087492
[TBL] [Abstract][Full Text] [Related]
15. Barrel rotation evoked by intracerebroventricular vasopressin injections in conscious rats. II. Visual/vestibular interactions and efficacy of antiseizure drugs.
Wurpel JN; Dundore RL; Barbella YR; Balaban CD; Keil LC; Severs WB
Brain Res; 1986 Feb; 365(1):30-41. PubMed ID: 3484995
[TBL] [Abstract][Full Text] [Related]
16. Intracerebroventricular treatment with vasopressin V1-receptor antagonist inhibits centrally-mediated pressor response to clonidine in conscious rats.
Nakamura S; Kawasaki H; Takasaki K
Jpn J Pharmacol; 1993 Dec; 63(4):447-53. PubMed ID: 8121079
[TBL] [Abstract][Full Text] [Related]
17. Role of L-glutamate in systemic AVP-induced hypothermia.
Paro FM; Almeida MC; Carnio EC; Branco LG
J Appl Physiol (1985); 2003 Jan; 94(1):271-7. PubMed ID: 12391090
[TBL] [Abstract][Full Text] [Related]
18. Enhanced pressor responses to ICV vasopressin after pretreatment with oxytocin.
Poulin P; Komulainen A; Takahashi Y; Pittman QJ
Am J Physiol; 1994 Feb; 266(2 Pt 2):R592-8. PubMed ID: 8141420
[TBL] [Abstract][Full Text] [Related]
19. Hindlimb paralytic effects of arginine vasopressin and related peptides following spinal subarachnoid injection in the rat.
Long JB; Martinez-Arizala A; Rigamonti DD; Holaday JW
Peptides; 1988; 9(6):1335-44. PubMed ID: 3247252
[TBL] [Abstract][Full Text] [Related]
20. Vasopressin-induced antipyresis in the medial amygdaloid nucleus of conscious rats.
Federico P; Veale WL; Pittman QJ
Am J Physiol; 1992 May; 262(5 Pt 2):R901-8. PubMed ID: 1534208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
